Are you Dr. Loghin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 34 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Monica Loghin, MD is a board certified neurologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Washington, and Louisiana. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- University of Texas Health Science Center at HoustonResidency, Neurology, 2000 - 2003
- University of Texas Health Science Center at HoustonInternship, Internal Medicine, 1999 - 2000
- University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1983
Certifications & Licensure
- FL State Medical License 2021 - Present
- TN State Medical License 2023 - 2026
- GA State Medical License 2023 - 2025
- WA State Medical License 2023 - 2024
- LA State Medical License 2023 - 2024
- MS State Medical License 2023 - 2024
- TX State Medical License 2006 - 2024
- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting Start of enrollment: 2017 Jan 20
Publications & Presentations
PubMed
- Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis.Rituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, Arnold C Paulino, Mary Frances McAleer, Amol Ghia, Jing Li, Debra Nana Yeboa, Monica Loghin, Rebecca Harrison, Bar...> ;Neuro-Oncology Advances. 2022 Aug 20
- 32 citationsDistinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, ...> ;Nature Communications. 2022 Apr 12
- 86 citationsWindow-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.John de Groot, Marta Penas-Prado, Kristin Alfaro-Munoz, Kathy Hunter, Be Lian Pei, Barbara O’Brien, Shiao Pei Weathers, Monica Loghin, Carlos Kamiya Matsouka, W. K. Al...> ;Neuro-Oncology. 2020 Apr 15
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas